Welcome to Eurofins Advinus
A premier preclinical and development stage contract research company for regulatory Toxicology (Safety Assessment), CMC services, DMPK and Analytical R&D Services. With over 30 years of GLP compliance and certification, Eurofins Advinus serves diverse industries such as Biotech, Pharmaceutical, Biological, Agrochemical, Nutraceutical and Cosmetic. Eurofins Advinus is the only contract research organization (CRO) in India to have developed data in support of 70+ end-to-end IND enabling packages to be submitted to global regulators such as USFDA, EMA, MHRA, Health Canada and others.
Meet us at
Virtual Conference
11th – 13th May 2021
EUROFINS ADVINUS' ACHIEVEMENTS
YEARS OF
GLP EXPERIENCE
IND PACKAGES
CARCINOGENICITY STUDIES
REGULATORY STUDIES
FACILITY TOUR
NEWS AND EVENTS
State Level Safety Awards Ceremony
Dr. Upadhya Timmanna, SVP and National Division Leader Biopharma and… more
Eurofins announces acquisition of assets of Gomti Life Sciences
Eurofins, through Eurofins Advinus, acquires all assets of Gomti Life… more
Eurofins Advinus Diwali Celebration
Eurofins Advinus Diwali celebrations... rangoli and traditional wear add colour… more
Eurofins Advinus at BIO International Convention - 2019 , Philadelphia, USA
Eurofins Advinus at 2019 - BIO International Convention, Philadelphia, USA more
CASE STUDIES - SEE HOW OUR SCIENCE CAN DRIVE YOUR RESEARCH & DEVELOPMENT
WHAT OUR CLIENTS SAY
-
I would like to…
I would like to thank the entire Advinus team for their tremendous support in the submission of two INDs with the US FDA. The Advinus team performed multiple in vitro and in vivo IND enabling studies with the highest scientific quality while meeting very aggressive timelines. The Advinus team displayed outstanding scientific competence and professionalism in conducting studies, and the quality of study reports was top notch. Their "can do" attitude was much appreciated and I look forward to collaborating with Advinus in future projects.
Kollol Pal, PhD, MBA – CEO , Pyramid Biosciences, Inc. Waltham, MA, USA
-
I would like to…
I would like to thank the entire Advinus team for their hard work and dedication. Recently, we have worked with Advinus on 2 INDs and both have been successfully submitted to US FDA. Advinus team is very dedicated and deliver a high quality reports and SEND data for IND submission. Team communication is excellent and they have very talented individuals with expertise in their field. I look forward to working with Advinus in future projects.
Vijaypal Reddy, DVM, PhD – Vice President, Nonclinical Safety Assessment, Pyramid BioSciences, Inc. Waltham, MA, USA
-
Revere has had a…
Revere has had a first-rate and productive partnership with Eurofins Advinus, Bangalore, India for over 2 years. During this time, we have performed ADME/DMPK and IND safety assessment studies at Eurofins Advinus. The team was highly experienced, professional, and enthusiastic, providing scientific insights and communicating effectively, while addressing any technical challenges during the engagement period. Amid the COVID pandemic, all our timelines were met, and the quality of the data and reports were excellent. We are extremely pleased with the services provided by Eurofins Advinus for our preclinical drug development program and IND-enabling studies and would enthusiastically recommend their high-quality services to others.
Jedd Levine, Chief Medical Officer, Revere Pharmaceuticals, USA
-
The Eurofins Advinus team…
The Eurofins Advinus team has shown excellent performance in progressing the chemistry and delivering critical compounds which have helped us in advancing the project and answering very pertinent hypothesis to understand the SAR. The team deserves appreciation for meeting deliverables par excellence, even through the scale-up synthesis in a brief period with high quality and purity for advancing in-vivo-studies.
Dr. Shahul Hameed, Chief Product Officer, Bugworks Research Inc